Home
DNLI

DNLI

Denali Therapeutics Inc.

as of 12-05-2025 3:35pm EST

$20.00

$0.11

-0.57%

Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Chart Type:

Time Range:

Founded:	2013	Country:	United States
Employees:	N/A	City:	SOUTH SAN FRANCISCO
Market Cap:	2.5B	IPO Year:	2017
Target Price:	$32.64	AVG Volume (30 days):	1.4M
Analyst Decision:	Strong Buy	Number of Analysts:	13
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-2.91	EPS Growth:	N/A
52 Week Low/High:	$10.57 - $26.18	Next Earning Date:	11-06-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	94232.03%

AI-Powered DNLI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold

Model Accuracy: 67.57%

67.57%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full DNLI Forecast & Prediction with Hourly Data

Compare DNLI vs Leading Stocks

See how DNLI stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free DNLI Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "DNLI Denali Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.